Bernstein Lab / Cancer Epigenetics

Cancer Epigenetics

Laura Hofman

Laura is a PhD student in the Biological and Biomedical Sciences (BBS) program at Harvard Medical School. She majored in Biomedical Sciences at Utrecht University in The Netherlands. Previously, she studied cancer immunotherapy in Dr. Jarno Drost’s lab at the Princess Máxima Center for Pediatric Oncology and genome editing in Prof. Jennifer Doudna’s lab at … Continued

Shelby Roseman, PhD

Shelby joined the lab as a research fellow in October 2023 after completing her PhD at Harvard University. During her PhD, she used chemical genomics to study 3D chromatin structure. She is interested in understanding and targeting the epigenetic mechanisms that contribute to cancer.

James Morrow, MD, PhD

James is a Pediatric Oncology Fellow at Dana-Farber/Boston Children’s Hospital where he currently treats pediatric patients with cancer diagnoses. He completed his MD/PhD at Case Western Reserve University. His graduate work identified enhancer dysregulation as a driver of osteosarcoma metastasis. He joined the Bernstein lab in September 2022 as a research fellow. His work will apply single cell … Continued

Salva Casani Galdon, PhD

Salva is a computational biologist interested in how chromatin changes drive aberrant gene expression regulation in cancer cells. He is currently working in defining transcriptional regulatory circuits in liposarcoma.

Alba Meira, PhD

Alba joined the lab in 2021 as a Sir Henry Wellcome Fellow. Originally from Spain, she undertook her PhD at the University of Oxford before moving to Boston. She is interested in deciphering in the epigenetic mechanisms that lead to tumor development and evolution using single cell technologies.